SpaceX, Rackspace surge premarket; Edgewise Therapeutics, Huntsman fall
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Robinhood Markets (HOOD) PT Raised to $110 at Argus, 'Announces 10% headcount reduction; raising target'
June 17, 2026 7:16 AM EDTArgus analyst Stephen Biggar raised the price target on Robinhood Markets (NASDAQ: HOOD) to $110.00 (from $90.00) while maintaining a Buy rating.
The analyst comments "Announces 10% headcount reduction; raising target On June 16, the company said it would implement a workforce reduction involving 10% of its employees, which recently numbered 2,900, as it seeks a less heavily... More
Truist on SPX Technologies (SPXC): 'on track to achieve financial targets early'
June 16, 2026 3:43 PM EDTTruist Securities analyst Jamie Cook reiterated a Buy rating and $261.00 price target on SPX Technologies (NYSE: SPXC)
The analyst comments "Upside to revenue opportunity from capacity expansion: SPXC is investing to expand capacity for custom air handling and data center cooling products at both existing facilities (including Mirabel and Olathe) and new facilities (in Nashville, TN, and Madison, AL). Management is increasingly confident in the companys ability to drive more throughput, efficiency, and productivity at these facilities; recall last quarter SPXC noted these investments are expected to add ~$700M in incremental capacity by... More
Edgewise Therapeutics (EWTX) PT Raised to $52 at Leerink
June 16, 2026 1:08 PM EDTLeerink analyst Joseph Schwartz raised the price target on Edgewise Therapeutics (NASDAQ: EWTX) to $52.00 (from $50.00) while maintaining a Outperform rating.
The analyst comments "We continue to think that CIRRUS Part D checks the key boxes for EDG-7500 across obstructive (oHCM) and non-obstructive... More
